Scott Lippman

Title(s)Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting Signaling Vulnerabilities for Oral Cancer Prevention
    NIH R01DE026644Jan 1, 2017 - Dec 31, 2021
    Role: Co-Principal Investigator
    Molecular-Based Therapy for Oral Cancer Prevention
    NIH P01CA106451Aug 1, 2004 - Jul 31, 2012
    Role: Principal Investigator
    U10 Full Member Application Affiliated with SWOG
    NIH U10CA105409Jul 26, 2004 - Dec 31, 2015
    Role: Principal Investigator
    Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
    NIH N01CN35159-8-0-1Sep 30, 2003 - Sep 29, 2012
    Role: Principal Investigator
    M D Anderson Cancer Center Head & Neck SPORE
    NIH P50CA097007Sep 30, 2002 - Jul 31, 2015
    Role: Principal Investigator
    PHASE III STUDY OF FENRETINIDE IN BLADDER CARCINOFENESIS
    NIH U01CA077150Sep 30, 1997 - Jul 31, 2004
    Role: Principal Investigator
    Specialized Cancer Center Support Grant
    NIH P30CA023100Jul 1, 1996 - Apr 30, 2024
    Role: Principal Investigator
    BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH &PROGRESSION
    NIH P01CA068233May 6, 1996 - Mar 31, 2005
    Role: Co-Investigator
    PHASE II CLINICAL TRIALS OF NEW CHEMOPRVENTIVE AGENTS
    NIH/NCI N01CN065004Oct 2, 1995 - Jun 30, 2000
    Role: Principal Investigator
    BIOLOGY AND CHEMOPREVENTION OF HEAD AND NECK CANCER
    NIH P01CA052051Aug 5, 1991 - Nov 30, 2004
    Role: Co-Investigator
    Biology of the Prostate Cancer Prevention Trial (PCPT)
    NIH P01CA108964Apr 30, 2014
    Role: Principal Investigator
    Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
    NIH/NCI N01CN35159Sep 29, 2008
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. JCI Insight. 2021 Jul 13. Gutkind JS, Molinolo A, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde DM, Rock LD, Rosin MP, Coffey CS, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HHS, Lippman SM, Szabo E. PMID: 34255745.
      View in: PubMed   Mentions:    Fields:    
    2. Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss. Proc Natl Acad Sci U S A. 2021 May 11; 118(19). William WN, Zhao X, Bianchi JJ, Lin HY, Cheng P, Lee JJ, Carter H, Alexandrov LB, Abraham JP, Spetzler DB, Dubinett SM, Cleveland DW, Cavenee W, Davoli T, Lippman SM. PMID: 33952700.
      View in: PubMed   Mentions:    Fields:    
    3. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. Lancet Oncol. 2021 May 11. Sacco AG, Chen R, Worden FP, Wong DJL, Adkins D, Swiecicki P, Chai-Ho W, Oppelt P, Ghosh D, Bykowski J, Molinolo A, Pittman E, Estrada MV, Gold K, Daniels G, Lippman SM, Natsuhara A, Messer K, Cohen EEW. PMID: 33989559.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    4. Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial. Nutr Cancer. 2021 Jan 29; 1-8. Chadid S, Song X, Schenk JM, Gurel B, Lucia MS, Thompson IM, Neuhouser ML, Goodman PJ, Parnes HL, Lippman SM, Nelson WG, De Marzo AM, Platz EA. PMID: 33511883.
      View in: PubMed   Mentions:    Fields:    
    5. Attrition of Patients on a Precision Oncology Trial: Analysis of the I-PREDICT Experience. Oncologist. 2020 11; 25(11):e1803-e1806. Bohan SS, Sicklick JK, Kato S, Okamura R, Miller VA, Leyland-Jones B, Lippman SM, Kurzrock R. PMID: 32949172.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy. Nat Commun. 2020 10 02; 11(1):4965. Kato S, Kim KH, Lim HJ, Boichard A, Nikanjam M, Weihe E, Kuo DJ, Eskander RN, Goodman A, Galanina N, Fanta PT, Schwab RB, Shatsky R, Plaxe SC, Sharabi A, Stites E, Adashek JJ, Okamura R, Lee S, Lippman SM, Sicklick JK, Kurzrock R. PMID: 33009371.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    7. Shining Light on the COVID-19 Pandemic: A Vitamin D Receptor Checkpoint in Defense of Unregulated Wound Healing. Cell Metab. 2020 11 03; 32(5):704-709. Evans RM, Lippman SM. PMID: 32941797.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2020 08; 80(11):895-905. Chadid S, Barber JR, Nelson WG, Gurel B, Lucia MS, Thompson IM, Goodman PJ, Stanczyk FZ, Parnes HL, Lippman SM, De Marzo AM, Platz EA. PMID: 32506665.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Author Correction: Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2020 Mar 23; 10(1):5514. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. PMID: 32251345.
      View in: PubMed   Mentions:    Fields:    
    10. A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment. Am J Phys Med Rehabil. 2020 03; 99(3):233-240. Ha D, Kerr J, Ries AL, Fuster MM, Lippman SM, Murphy JD. PMID: 31361623.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. The paradox of cancer genes in non-malignant conditions: implications for precision medicine. Genome Med. 2020 02 17; 12(1):16. Adashek JJ, Kato S, Lippman SM, Kurzrock R. PMID: 32066498.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    12. Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies. Int J Cancer. 2020 06 15; 146(12):3450-3460. Kato S, Okamura R, Sicklick JK, Daniels GA, Hong DS, Goodman A, Weihe E, Lee S, Khalid N, Collier R, Mareboina M, Riviere P, Whitchurch TJ, Fanta PT, Lippman SM, Kurzrock R. PMID: 31782524.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    13. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer. 2020 Oct; 28(10):4707-4720. Ha D, Ries AL, Lippman SM, Fuster MM. PMID: 31965306.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Targeting mTOR in Head and Neck Cancer-Response. Clin Cancer Res. 2019 11 01; 25(21):6555. Gutkind JS, Day TA, Lippman SM, Szabo E. PMID: 31676588.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. Cancer Immunol Res. 2019 10; 7(10):1570-1573. Goodman AM, Sokol ES, Frampton GM, Lippman SM, Kurzrock R. PMID: 31405947.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    16. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. . 2019 10; 18(10):1852-1862. Choi IS, Kato S, Fanta PT, Leichman L, Okamura R, Raymond VM, Lanman RB, Lippman SM, Kurzrock R. PMID: 31320401.
      View in: PubMed   Mentions:
    17. Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells. Cancer Res. 2019 09 01; 79(17):4360-4370. Wu X, Yeerna H, Goto Y, Ando T, Wu VH, Zhang X, Wang Z, Amornphimoltham P, Murphy AN, Tamayo P, Chen Q, Lippman SM, Gutkind JS. PMID: 31292160.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    18. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study. Nat Med. 2019 05; 25(5):744-750. Sicklick JK, Kato S, Okamura R, Schwaederle M, Hahn ME, Williams CB, De P, Krie A, Piccioni DE, Miller VA, Ross JS, Benson A, Webster J, Stephens PJ, Lee JJ, Fanta PT, Lippman SM, Leyland-Jones B, Kurzrock R. PMID: 31011206.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    19. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res. 2019 04 01; 79(7):1438-1450. Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS. PMID: 30894372.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    20. Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer. Cancer Res. 2019 02 15; 79(4):689-698. Murtuza A, Bulbul A, Shen JP, Keshavarzian P, Woodward BD, Lopez-Diaz FJ, Lippman SM, Husain H. PMID: 30718357.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    21. Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival. JCO Precis Oncol. 2019; 3. Kato S, Schwaederlé MC, Fanta PT, Okamura R, Leichman L, Lippman SM, Lanman RB, Raymond VM, Talasaz A, Kurzrock R. PMID: 31032472.
      View in: PubMed   Mentions:
    22. Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. JCO Precis Oncol. 2019; 3. Kato S, Okamura R, Mareboina M, Lee S, Goodman A, Patel SP, Fanta PT, Schwab RB, Vu P, Raymond VM, Lanman RB, Sicklick JK, Lippman SM, Kurzrock R. PMID: 31058253.
      View in: PubMed   Mentions:
    23. APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. Oncoimmunology. 2019; 8(3):1550341. Boichard A, Pham TV, Yeerna H, Goodman A, Tamayo P, Lippman S, Frampton GM, Tsigelny IF, Kurzrock R. PMID: 30723579.
      View in: PubMed   Mentions:
    24. AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778. Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ET. PMID: 30530635.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    25. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164. Day TA, Shirai K, O'Brien PE, Matheus MG, Godwin K, Sood AJ, Kompelli A, Vick JA, Martin D, Vitale-Cross L, Callejas-Varela JL, Wang Z, Wu X, Harismendy O, Molinolo AA, Lippman SM, Van Waes C, Szabo E, Gutkind JS. PMID: 30420444.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    26. Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1175-1176. Goggins MG, Lippman SM, Constantinou PE, Jacks T, Petersen GM, Syngal S, Maitra A. PMID: 30325853.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. Clin Cancer Res. 2018 12 15; 24(24):6248-6256. Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R. PMID: 30348637.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    28. Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors. JAMA Oncol. 2018 09 01; 4(9):1237-1244. Goodman AM, Piccioni D, Kato S, Boichard A, Wang HY, Frampton G, Lippman SM, Connelly C, Fabrizio D, Miller V, Sicklick JK, Kurzrock R. PMID: 29902298.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    29. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients. Sci Rep. 2018 Jul 13; 8(1):10640. Pierzynski JA, Ye Y, Lippman SM, Rodriguez MA, Wu X, Hildebrandt MAT. PMID: 30006595.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    30. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor. Nat Commun. 2018 07 09; 9(1):2372. Martin D, Degese MS, Vitale-Cross L, Iglesias-Bartolome R, Valera JLC, Wang Z, Feng X, Yeerna H, Vadmal V, Moroishi T, Thorne RF, Zaida M, Siegele B, Cheong SC, Molinolo AA, Samuels Y, Tamayo P, Guan KL, Lippman SM, Lyons JG, Gutkind JS. PMID: 29985391.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    31. The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Cancer Prev Res (Phila). 2018 10; 11(10):607-620. Zhang T, Wang Q, Fredimoses M, Gao G, Wang K, Chen H, Wang T, Oi N, Zykova TA, Reddy K, Yao K, Ma W, Chang X, Lee MH, Rathore MG, Bode AM, Ashida H, Lippman SM, Dong Z. PMID: 29980517.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    32. Positive Surgical Margins in the 10 Most Common Solid Cancers. Sci Rep. 2018 04 09; 8(1):5686. Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT. PMID: 29632347.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    33. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3). Saintigny P, William WN, Foy JP, Papadimitrakopoulou V, Lang W, Zhang L, Fan YH, Feng L, Kim ES, El-Naggar AK, Lee JJ, Mao L, Hong WK, Lingen MW, Lippman SM. PMID: 29617836.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    34. Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist. 2018 05; 23(5):586-593. Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R. PMID: 29487225.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Jul; 26(7):2459-2469. Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. PMID: 29429006.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 2018 02 09; 39(2):125-133. Tang L, Platek ME, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JKV, Santella RM, Hsing A, Figg WD, Lippman SM, Thompson IM, Ambrosone CB. PMID: 29228205.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma. Eur J Cancer. 2018 03; 92:20-32. Deng Y, Tu H, Pierzynski JA, Miller ED, Gu X, Huang M, Chang DW, Ye Y, Hildebrandt MAT, Klein AP, Zhao R, Lippman SM, Wu X. PMID: 29413686.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706. Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. PMID: 29208398.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    39. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial. J Am Acad Dermatol. 2017 Dec; 77(6):1110-1113.e2. William WN, Feng L, Ferrarotto R, Ginsberg L, Kies M, Lippman S, Glisson B, Kim ES. PMID: 28964539.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    40. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts. Cancer Epidemiol Biomarkers Prev. 2017 10; 26(10):1549-1557. Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman SM, Parnes HL, Thompson IM, Goodman PJ, Tangen CM, De Marzo AM. PMID: 28754796.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    41. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017 08; 18(8):e457-e471. Kerr J, Anderson C, Lippman SM. PMID: 28759385.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    42. Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. Cancer Res. 2017 08 15; 77(16):4238-4246. Kato S, Krishnamurthy N, Banks KC, De P, Williams K, Williams C, Leyland-Jones B, Lippman SM, Lanman RB, Kurzrock R. PMID: 28642281.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    43. Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology. . 2017 05; 16(5):948-955. Husain H, Nykin D, Bui N, Quan D, Gomez G, Woodward B, Venkatapathy S, Duttagupta R, Fung E, Lippman SM, Kurzrock R. PMID: 28468865.
      View in: PubMed   Mentions:
    44. Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clin Cancer Res. 2017 Aug 15; 23(16):4716-4723. Husain H, Melnikova VO, Kosco K, Woodward B, More S, Pingle SC, Weihe E, Park BH, Tewari M, Erlander MG, Cohen E, Lippman SM, Kurzrock R. PMID: 28420725.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    45. Precancer Atlas to Drive Precision Prevention Trials. Cancer Res. 2017 04 01; 77(7):1510-1541. Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman SM. PMID: 28373404.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    46. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. Prostate. 2017 Jun; 77(8):908-919. Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, De Marzo AM, Drake CG, Platz EA. PMID: 28317149.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    47. Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. J Oncol Pharm Pract. 2018 04; 24(3):229-231. Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC. PMID: 28436313.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer. Cancer Discov. 2017 04; 7(4):410-423. Carter H, Marty R, Hofree M, Gross AM, Jensen J, Fisch KM, Wu X, DeBoever C, Van Nostrand EL, Song Y, Wheeler E, Kreisberg JF, Lippman SM, Yeo GW, Gutkind JS, Ideker T. PMID: 28188128.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    49. Translating Germline Cancer Risk into Precision Prevention. Cell. 2017 02 09; 168(4):566-570. Yurgelun MB, Chenevix-Trench G, Lippman SM. PMID: 28187278.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    50. Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma. Oral Oncol. 2017 02; 65:68-75. Krishnan AR, Korrapati A, Zou AE, Qu Y, Wang XQ, Califano JA, Wang-Rodriguez J, Lippman SM, Hovell MF, Ongkeko WM. PMID: 28109471.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank. Cancer Prev Res (Phila). 2017 Feb; 10(2):99-107. McCaskill-Stevens W, Pearson DC, Kramer BS, Ford LG, Lippman SM. PMID: 27965286.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    52. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2016 11 02; 6:36482. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. PMID: 27805040.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    53. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer. J Oncol Pharm Pract. 2017 Dec; 23(8):638-640. Dasanu CA, Lippman SM, Plaxe SC. PMID: 27824586.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize. Nat Commun. 2016 10 04; 7:13019. Adams SR, Yang HC, Savariar EN, Aguilera J, Crisp JL, Jones KA, Whitney MA, Lippman SM, Cohen EE, Tsien RY, Advani SJ. PMID: 27698471.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    55. Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A. 2016 09 27; 113(39):10750-8. Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman SM. PMID: 27638202.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    56. Sleep and Breathing … and Cancer? Cancer Prev Res (Phila). 2016 11; 9(11):821-827. Owens RL, Gold KA, Gozal D, Peppard PE, Jun JC, Dannenberg AJ, Lippman SM, Malhotra A, UCSD Sleep and Cancer Symposium Group . PMID: 27604751.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    57. The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget. 2016 08 09; 7(32):51211-51222. Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, Yu V, Singh P, Grandis JR, King CC, Lippman SM, Wang XQ, Hinton A, Ongkeko WM. PMID: 27323410.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    58. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget. 2016 Jun 14; 7(24):35932-35945. Foy JP, Tortereau A, Caulin C, Le Texier V, Lavergne E, Thomas E, Chabaud S, Perol D, Lachuer J, Lang W, Hong WK, Goudot P, Lippman SM, Bertolus C, Saintigny P. PMID: 27027432.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    59. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. Breast Cancer Res Treat. 2016 07; 158(1):67-77. Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N. PMID: 27287781.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    60. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. PMID: 27322462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    61. The Conundrum of Genetic "Drivers" in Benign Conditions. J Natl Cancer Inst. 2016 08; 108(8). Kato S, Lippman SM, Flaherty KT, Kurzrock R. PMID: 27059373.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    62. Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress. Free Radic Biol Med. 2016 06; 95:349-56. Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline J, Goodman PJ, Minasian LM, Lippman SM, Klein E, Cassano PA. PMID: 27012420.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    63. A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers. Oncotarget. 2016 Mar 08; 7(10):10696-709. Yamaguchi K, Iglesias-Bartolomé R, Wang Z, Callejas-Valera JL, Amornphimoltham P, Molinolo AA, Cohen EE, Califano JA, Lippman SM, Luo J, Gutkind JS. PMID: 26882569.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    64. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. . 2016 04; 15(4):743-52. Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman SM, Kurzrock R. PMID: 26873727.
      View in: PubMed   Mentions:
    65. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16. William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM. PMID: 26540028.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    66. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. Prostate. 2016 May; 76(6):565-74. Winchester DA, Gurel B, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Thompson IM, Xu J, Zheng SL, Lucia MS, Lippman SM, Parnes HL, Isaacs WB, Drake CG, De Marzo AM, Platz EA. PMID: 26771888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Catalyzing Cancer Prevention Research CaPR: A New Year/New Opportunities. Cancer Prev Res (Phila). 2016 Jan; 9(1):1. Lippman SM. PMID: 26744448.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Transforming Cancer Prevention through Precision Medicine and Immune-oncology. Cancer Prev Res (Phila). 2016 Jan; 9(1):2-10. Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, Davidson NE, Foti M, Lippman SM. PMID: 26744449.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    69. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):463-9. Murtola TJ, Gurel B, Umbehr M, Lucia MS, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman SM, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, Platz EA. PMID: 26715424.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst. 2016 Feb; 108(2). Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS. PMID: 26547931.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsPHPublic Health
    71. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. Oncotarget. 2015 Oct 20; 6(32):32602-9. Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R. PMID: 26418953.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    72. Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prev Res (Phila). 2015 Dec; 8(12):1131-7. Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ. PMID: 26471236.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    73. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prev Res (Phila). 2015 Nov; 8(11):1027-35. Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. PMID: 26342026.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    74. Molecular cancer prevention: Current status and future directions. CA Cancer J Clin. 2015 Sep-Oct; 65(5):345-83. Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET. PMID: 26284997.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    75. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1507-15. Nash SH, Till C, Song X, Lucia MS, Parnes HL, Thompson IM, Lippman SM, Platz EA, Schenk J. PMID: 26269564.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    76. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. PMID: 26211600.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    77. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer. Oncotarget. 2015 Jun 30; 6(18):16746-56. Kim JS, Kim ES, Liu D, Lee JJ, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee E, Lee HY. PMID: 25944691.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    78. The cancer cell map initiative: defining the hallmark networks of cancer. Mol Cell. 2015 May 21; 58(4):690-8. Krogan NJ, Lippman S, Agard DA, Ashworth A, Ideker T. PMID: 26000852.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    79. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila). 2015 Jul; 8(7):590-6. Nash SH, Schenk JM, Kristal AR, Goodman PJ, Lucia MS, Parnes HL, Thompson IM, Lippman SM, Song X, Gurel B, De Marzo A, Platz EA. PMID: 25926387.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2015 Aug 01; 75(11):1160-6. Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman SM, Thompson IM, Platz EA, Meeker AK. PMID: 25893825.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    81. A randomized controlled trial of vitamin E and selenium on rate of decline in lung function. Respir Res. 2015 Mar 11; 16:35. Cassano PA, Guertin KA, Kristal AR, Ritchie KE, Bertoia ML, Arnold KB, Crowley JJ, Hartline J, Goodman PJ, Tangen CM, Minasian LM, Lippman SM, Klein E. PMID: 25889509.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    82. Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease. Urology. 2015 Mar; 85(3):616-20. Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Ambrosone CB, Thompson IM. PMID: 25733274.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    83. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol. 2015 May; 51(5):470-5. Raju SC, Hauff SJ, Lemieux AJ, Orosco RK, Gross AM, Nguyen LT, Savariar E, Moss W, Whitney M, Cohen EE, Lippman SM, Tsien RY, Ideker T, Advani SJ, Nguyen QT. PMID: 25735654.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    84. Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study. J Thorac Oncol. 2015 Feb; 10(2):302-8. Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. PMID: 25299235.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    85. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan; 133(1):17-24. Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Blanke CD, Klein EA. PMID: 25232809.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    86. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 01; 21(1):193-200. Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman SM, Wu X. PMID: 25336700.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    87. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. PMID: 25316813.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    88. Phase I study of intermittent oral dosing of the insulin-like growth factor-1 and insulin receptors inhibitor OSI-906 in patients with advanced solid tumors. Clin Cancer Res. 2015 Feb 15; 21(4):693-700. Jones RL, Kim ES, Nava-Parada P, Alam S, Johnson FM, Stephens AW, Simantov R, Poondru S, Gedrich R, Lippman SM, Kaye SB, Carden CP. PMID: 25208878.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    89. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):612-8. Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E, Nashi N, Hasselman J, Whitney M, Myers JN, Lippman SM, Tsien RY, Ideker T, Nguyen QT. PMID: 25091190.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    90. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep; 46(9):939-43. Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman SM, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. PMID: 25086664.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    91. Molecular tumor board: the University of California-San Diego Moores Cancer Center experience. Oncologist. 2014 Jun; 19(6):631-6. Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R. PMID: 24797821.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    92. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369. Pu X, Hildebrandt MA, Lu C, Roth JA, Stewart DJ, Zhao Y, Heist RS, Ye Y, Chang DW, Su L, Minna JD, Lippman SM, Spitz MR, Christiani DC, Wu X. PMID: 24755914.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    93. An integrin ß3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol. 2014 May; 16(5):457-68. Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman SM, Desgrosellier JS, Anand S, Weis SM, Cheresh DA. PMID: 24747441.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansAnimalsCells
    94. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):847-56. Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. PMID: 24748218.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    95. Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study. Carcinogenesis. 2014 Aug; 35(8):1760-4. He Y, Gong Y, Gu J, Lee JJ, Lippman SM, Wu X. PMID: 24743515.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    96. John A. Milner: in memoriam (1947-2013). Cancer Prev Res (Phila). 2014 Apr; 7(4):373-4. Greenwald P, Stoner G, Colburn N, Lippman SM. PMID: 24695271.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar; 106(3):djt456. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. PMID: 24563519.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    98. Letter from the Editor. Cancer Prev Res (Phila). 2014 Feb; 7(2):179-81. Lippman SM. PMID: 24464731.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    99. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer. Clin Lung Cancer. 2014 May; 15(3):213-21. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 24485233.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial. Clin Cancer Res. 2013 Dec 15; 19(24):6967-75. Blumenschein GR, Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman SM. PMID: 24166906.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    101. Human epidermal receptor 2-amplified salivary duct carcinoma: regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment. Head Neck. 2014 Mar; 36(3):E25-7. Falchook GS, Lippman SM, Bastida CC, Kurzrock R. PMID: 23852769.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    102. Combating resistance to anti-IGFR antibody by targeting the integrin ß3-Src pathway. J Natl Cancer Inst. 2013 Oct 16; 105(20):1558-70. Shin DH, Lee HJ, Min HY, Choi SP, Lee MS, Lee JW, Johnson FM, Mehta K, Lippman SM, Glisson BS, Lee HY. PMID: 24092920.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    103. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer. 2013 Dec 15; 119(24):4277-83. Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J. PMID: 24105340.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    104. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol. 2013 Nov 20; 31(33):4179-87. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman SM, Ruckdeschel J, Khuri FR. PMID: 24002495.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    105. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG, Wade JL, Lippman SM. PMID: 23835710.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    106. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, El-Naggar AK. PMID: 23825564.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    107. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 01; 73(15):4801-9. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. PMID: 23774211.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    108. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013 Jul; 123(7):2965-8. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman SM, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. PMID: 23778141.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    109. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013 Jul 01; 73(13):4028-38. Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, Huang MS, Chang DW, Li Y, Pankratz VS, Minna JD, Hong WK, Hildebrandt MA, Hsiung CA, Yang P. PMID: 23704207.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    110. Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol. 2013 May; 8(5):658-61. Tsao AS, Liu S, Lee JJ, Alden CM, Blumenschein GR, Herbst R, Davis SE, Kim E, Lippman S, Heymach J, Tran H, Tang X, Wistuba I, Hong WK. PMID: 23584298.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    111. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57. Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK. PMID: 23583282.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    112. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol. 2013 Apr; 8(4):436-42. Tam AL, Kim ES, Lee JJ, Ensor JE, Hicks ME, Tang X, Blumenschein GR, Alden CM, Erasmus JJ, Tsao A, Lippman SM, Hong WK, Wistuba II, Gupta S. PMID: 23442309.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    113. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addict Biol. 2013 Sep; 18(5):786-99. Aarde SM, Angrish D, Barlow DJ, Wright MJ, Vandewater SA, Creehan KM, Houseknecht KL, Dickerson TJ, Taffe MA. PMID: 23378343.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    114. Natural-agent mechanisms and early-phase clinical development. Top Curr Chem. 2013; 329:241-52. Wang JL, Gold KA, Lippman SM. PMID: 22851156.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Looking forward to 2013--saluting the exceptional year in 2012. Cancer Prev Res (Phila). 2013 Jan; 6(1):1-3. Lippman SM. PMID: 23282630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma. Am J Pathol. 2013 Feb; 182(2):529-39. Yan W, Shih J, Rodriguez-Canales J, Tangrea MA, Player A, Diao L, Hu N, Goldstein AM, Wang J, Taylor PR, Lippman SM, Wistuba II, Emmert-Buck MR, Erickson HS. PMID: 23219752.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    117. Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol. 2012 Dec; 130(12):1608-11. El-Sawy T, Sabichi AL, Myers JN, Kies MS, William WN, Glisson BS, Lippman S, Esmaeli B. PMID: 23229707.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013 Jan 15; 73(2):571-82. Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, Kim ES, Herbst RS, Lippman SM, Wistuba II, Hong WK, Kurie JM, Koo JS. PMID: 23204236.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansAnimalsCells
    119. Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial. J Thorac Oncol. 2012 Nov; 7(11):1645-52. Tsao AS, Liu S, Lee JJ, Alden C, Blumenschein G, Herbst R, Davis SE, Kim E, Lippman S, Stewart D, Tang XM, Wistuba I, Hong WK. PMID: 23059780.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    120. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013 Jan 01; 19(1):279-90. Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Tumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJ, Bearss DJ, Warner SL, Foulks JM, Kanner SB, Gandhi V, Krett N, Rosen ST, Kim ES, Herbst RS, Blumenschein GR, Lee JJ, Lippman SM, Ang KK, Mills GB, Hong WK, Weinstein JN, Wistuba II, Coombes KR, Minna JD, Heymach JV. PMID: 23091115.
      View in: PubMed   Mentions: 370     Fields:    Translation:HumansAnimalsCells
    121. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 01; 18(21):5983-91. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. PMID: 22977190.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    122. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2012 Sep; 2(9):798-811. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman SM, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. PMID: 22961666.
      View in: PubMed   Mentions: 185     Fields:    Translation:HumansCells
    123. Associations of serum sex steroid hormone and 5a-androstane-3a,17ß-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1823-32. Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman SM, Hsing AW. PMID: 22879203.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    124. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012 Sep; 5(9):1144-54. Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman SM, Hershman DL. PMID: 22827973.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    125. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther. 2012 Sep; 11(9):2021-32. Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman SM, Girard L, Minna JD, Heymach JV, Johnson FM. PMID: 22807579.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    126. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis. 2012 Sep; 33(9):1699-706. Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman SM, Wu X. PMID: 22665367.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    127. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 01; 18(13):3705-13. Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. PMID: 22577058.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    128. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors. Cancer. 2012 Aug 15; 118(16):3993-4003. Kim WY, Prudkin L, Feng L, Kim ES, Hennessy B, Lee JS, Lee JJ, Glisson B, Lippman SM, Wistuba II, Hong WK, Lee HY. PMID: 22359227.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    129. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 08; 104(3):228-39. Ihle NT, Byers LA, Kim ES, Saintigny P, Lee JJ, Blumenschein GR, Tsao A, Liu S, Larsen JE, Wang J, Diao L, Coombes KR, Chen L, Zhang S, Abdelmelek MF, Tang X, Papadimitrakopoulou V, Minna JD, Lippman SM, Hong WK, Herbst RS, Wistuba II, Heymach JV, Powis G. PMID: 22247021.
      View in: PubMed   Mentions: 155     Fields:    Translation:HumansCells
    130. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1):103-19. Santarpia L, Lippman SM, El-Naggar AK. PMID: 22239440.
      View in: PubMed   Mentions: 230     Fields:    Translation:HumansAnimalsCells
    131. Letter from the editor. Cancer Prev Res (Phila). 2012 Jan; 5(1):1-2. Lippman SM. PMID: 22219161.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    132. An intermittent approach for cancer chemoprevention. Nat Rev Cancer. 2011 11 10; 11(12):879-85. Wu X, Lippman SM. PMID: 22071977.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    133. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet. 2011 Dec 17; 378(9809):2051-2. Chan AT, Lippman SM. PMID: 22036018.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    134. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306(14):1549-56. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Baker LH. PMID: 21990298.
      View in: PubMed   Mentions: 480     Fields:    Translation:Humans
    135. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48. Shin DH, Min HY, El-Naggar AK, Lippman SM, Glisson B, Lee HY. PMID: 21980128.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    136. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. PMID: 21976542.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    137. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71. Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. PMID: 21965272.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    138. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer. 2012 May 01; 118(9):2454-65. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 21952750.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    139. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011 Nov; 4(11):1761-9. Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman SM, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM. PMID: 21896650.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    140. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 2011 Oct; 32(10):1500-6. Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JK, Santella RM, Hsing A, Hoque A, Lippman SM, Thompson IM, Ambrosone CB. PMID: 21771722.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    141. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control. 2011 Aug; 22(8):1121-31. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman SM, Thompson IM, Ambrosone CB, Hoque A. PMID: 21667068.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    142. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 2011 Jun; 1(1):44-53. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman SM, Hong WK. PMID: 22586319.
      View in: PubMed   Mentions: 296     Fields:    Translation:HumansCTClinical Trials
    143. Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events. Blood. 2011 Sep 01; 118(9):2622-31. Kim JH, Choi DS, Lee OH, Oh SH, Lippman SM, Lee HY. PMID: 21551235.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    144. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6. Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. PMID: 21515830.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    145. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman SM, Hong WK, Spitz MR, Romkes M, Yang P. PMID: 21483023.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    146. Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila). 2011 Jan; 4(1):34-42. Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, Ferretti S, Pelosi G, Lazzeroni M, Serrano D, Lippman SM, Spaggiari L, Nardi-Pantoli A, Harari S, Varricchio C, Bonanni B. PMID: 21163939.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    147. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila). 2010 Dec; 3(12):1523-33. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM. PMID: 21149329.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    148. Phase II study of dasatinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010 Oct 20; 28(30):4609-15. Johnson FM, Bekele BN, Feng L, Wistuba I, Tang XM, Tran HT, Erasmus JJ, Hwang LL, Takebe N, Blumenschein GR, Lippman SM, Stewart DJ. PMID: 20855820.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCellsCTClinical Trials
    149. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23. Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. PMID: 20819778.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    150. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010 Aug 25; 5(8):e12402. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. PMID: 20811626.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    151. Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. Contemp Clin Trials. 2010 Nov; 31(6):612-9. Lazzeroni M, Guerrieri-Gonzaga A, Serrano D, Varricchio MC, Veronesi G, Radice D, Feroce I, Nardi-Pantoli A, Lippman SM, Szabo E, Bonanni B. PMID: 20719253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    152. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 01; 16(19):4722-31. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. PMID: 20702610.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    153. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1755-61. Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. PMID: 20627871.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    154. Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. J Clin Oncol. 2010 Aug 01; 28(22):3611-6. Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman SM, Seay TE, Flynn PJ, O'Reilly EM, Rowland KM, Wong RP, Benedetti J, Blanke CD. PMID: 20606094.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    155. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J Thorac Oncol. 2010 Jul; 5(7):940-9. Jacoby JJ, Erez B, Korshunova MV, Williams RR, Furutani K, Takahashi O, Kirkpatrick L, Lippman SM, Powis G, O'Reilly MS, Herbst RS. PMID: 20512076.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    156. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010 Jun 29; 2:15. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. PMID: 20587061.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCells
    157. Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38. Shureiqi I, Chen D, Day RS, Zuo X, Hochman FL, Ross WA, Cole RA, Moy O, Morris JS, Xiao L, Newman RA, Yang P, Lippman SM. PMID: 20570882.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    158. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. . 2010 Jun; 9(6):1755-63. Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman SM, Heymach JV. PMID: 20530716.
      View in: PubMed   Mentions:
    159. Mortality in the randomized, controlled lung intergroup trial of isotretinoin. Cancer Prev Res (Phila). 2010 Jun; 3(6):738-44. Lee JJ, Feng L, Reshef DS, Sabichi AL, Williams B, Rinsurongkawong W, Wistuba II, Lotan R, Lippman SM. PMID: 20501862.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    160. Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. Cancer. 2010 May 15; 116(10):2401-8. William WN, Kies MS, Fossella FV, Liu DD, Gladish G, Tse WH, Lee JJ, Hong WK, Lippman SM, Kim ES. PMID: 20225327.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    161. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy. Am J Clin Oncol. 2010 Apr; 33(2):148-52. William WN, Khuri FR, Fossella FV, Glisson BS, Zinner RG, Lee JJ, Herbst RS, Lippman SM, Kim ES. PMID: 19687727.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    162. Unprecedented opportunities and promise for cancer prevention research. Cancer Prev Res (Phila). 2010 Apr; 3(4):394-402. Blackburn EH, Tlsty TD, Lippman SM. PMID: 20354163.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    163. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 01; 78(3):667-74. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. PMID: 20171802.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    164. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010 Feb; 49(2):183-9. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. PMID: 19851984.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    165. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman SM, Hong WK, Wei Q. PMID: 20068090.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    166. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat. 2010 Jan; 31(1):67-73. Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, Reichardt JK. PMID: 19877174.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    167. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14. Kies MS, Holsinger FC, Lee JJ, William WN, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman SM, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V. PMID: 19917840.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCellsCTClinical Trials
    168. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila). 2009 Nov; 2(11):957-65. Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ. PMID: 19843689.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    169. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009 Oct 01; 15(19):6284-91. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman SM, Mao L. PMID: 19773378.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    170. Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res. 2009 Sep 15; 69(18):7439-48. Kim WY, Jin Q, Oh SH, Kim ES, Yang YJ, Lee DH, Feng L, Behrens C, Prudkin L, Miller YE, Lee JJ, Lippman SM, Hong WK, Wistuba II, Lee HY. PMID: 19738076.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    171. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology. 2009; 77(2):75-81. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. PMID: 19571599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    172. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24. Wu X, Spitz MR, Lee JJ, Lippman SM, Ye Y, Yang H, Khuri FR, Kim E, Gu J, Lotan R, Hong WK. PMID: 19584075.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    173. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial. J Clin Oncol. 2009 Aug 01; 27(22):3569-72. Platz EA, Lippman SM. PMID: 19528369.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    174. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009 Jul 01; 69(13):5269-84. Lippman SM, Hawk ET. PMID: 19491253.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    175. Cancer prevention research: back to the future. Cancer Prev Res (Phila). 2009 Jun; 2(6):503-13. Lippman SM. PMID: 19491288.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    176. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009 Jul 01; 27(19):3235-58. Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman SM, American Society of Clinical Oncology . PMID: 19470930.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    177. The changing face of phase 1 cancer clinical trials: new challenges in study requirements. Cancer. 2009 Apr 15; 115(8):1592-7. Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, Karp DD. PMID: 19165808.
      View in: PubMed   Mentions: 6     Fields:    
    178. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 2009 Apr 01; 115(7):1498-506. Pu X, Lippman SM, Yang H, Lee JJ, Wu X. PMID: 19197984.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    179. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009 May 20; 27(15):2509-15. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. PMID: 19332725.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCTClinical Trials
    180. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest. 2009 Sep; 136(3):701-709. William WN, Lin HY, Lee JJ, Lippman SM, Roth JA, Kim ES. PMID: 19318668.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    181. Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. . 2009 Mar; 8(3):521-32. Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman SM, Miller JH. PMID: 19276160.
      View in: PubMed   Mentions:
    182. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J Natl Cancer Inst. 2009 Mar 18; 101(6):363-5. Kristal AR, Lippman SM. PMID: 19276449.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    183. Molecular targets for cancer chemoprevention. Nat Rev Drug Discov. 2009 Mar; 8(3):213-25. William WN, Heymach JV, Kim ES, Lippman SM. PMID: 19247304.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    184. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04; 101(5):306-20. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. PMID: 19244175.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    185. Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors. Am J Clin Oncol. 2009 Feb; 32(1):15-9. William WN, Lee JL, Shin DM, Hong WK, Liu S, Lee JJ, Lippman SM, Khuri FR, Kim ES. PMID: 19194117.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    186. Cancer Prevention Research. Letter from the Editor. Cancer Prev Res (Phila). 2009 Jan; 2(1):1-2. Lippman SM. PMID: 19139009.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    187. High-dose fenretinide in oral leukoplakia. Cancer Prev Res (Phila). 2009 Jan; 2(1):22-6. William WN, Lee JJ, Lippman SM, Martin JW, Chakravarti N, Tran HT, Sabichi AL, Kim ES, Feng L, Lotan R, Papadimitrakopoulou VA. PMID: 19139014.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    188. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK. PMID: 19139013.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    189. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2009 Feb 01; 27(4):599-604. Papadimitrakopoulou VA, Lee JJ, William WN, Martin JW, Thomas M, Kim ES, Khuri FR, Shin DM, Feng L, Hong WK, Lippman SM. PMID: 19075276.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    190. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 07; 301(1):39-51. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA. PMID: 19066370.
      View in: PubMed   Mentions: 642     Fields:    Translation:HumansCTClinical Trials
    191. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 2008 Dec; 134(6):1349. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. PMID: 19059972.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    192. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet. 2008 Nov 22; 372(9652):1809-18. Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, Sun Y, Liao ML, Osterlind K, Reck M, Armour AA, Shepherd FA, Lippman SM, Douillard JY. PMID: 19027483.
      View in: PubMed   Mentions: 418     Fields:    Translation:HumansCTClinical Trials
    193. The future of molecular-targeted cancer chemoprevention. Gastroenterology. 2008 Dec; 135(6):1834-41. Lippman SM. PMID: 18996123.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    194. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95. Ye Y, Lippman SM, Lee JJ, Chen M, Frazier ML, Spitz MR, Wu X. PMID: 18823025.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    195. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors . PMID: 18990728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    196. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prev Res (Phila). 2008 Nov; 1(6):393-5. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman SM, CEBP Senior Editors and CaPR Deputy and Senior Editors . PMID: 19138984.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    197. Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst. 2008 Oct 15; 100(20):1420-3. Howe LR, Lippman SM. PMID: 18840814.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    198. Lung cancer. N Engl J Med. 2008 Sep 25; 359(13):1367-80. Herbst RS, Heymach JV, Lippman SM. PMID: 18815398.
      View in: PubMed   Mentions: 969     Fields:    Translation:HumansCells
    199. Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 2008 Aug 01; 68(15):6065-73. Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman SM, Wistuba II, Koo JS. PMID: 18676828.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    200. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11. Yang H, Lippman SM, Huang M, Jack Lee J, Wang W, Spitz MR, Wu X. PMID: 18579371.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    201. Inaugural issue of Cancer Prevention Research. Cancer Prev Res (Phila). 2008 Jun; 1(1):1-3. Lippman SM. PMID: 19138928.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    202. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 01; 112(9):2088-100. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. PMID: 18327819.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    203. Does the level of prostate cancer risk affect cancer prevention with finasteride? Urology. 2008 May; 71(5):854-7. Thompson IM, Tangen CM, Parnes HL, Lippman SM, Coltman CA. PMID: 18455628.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    204. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol. 2008 Apr 01; 26(10):1650-6. Goodwin JW, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS. PMID: 18375894.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    205. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res. 2008 Apr 01; 14(7):2095-101. Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. PMID: 18381950.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    206. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis. Cancer. 2008 Mar 01; 112(5):1058-65. Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. PMID: 18186497.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    207. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 2008 Jan 20; 26(3):354-60. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman SM, Mao L. PMID: 18202409.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    208. 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J. 2008 Jun; 22(6):1981-92. Zuo X, Shen L, Issa JP, Moy O, Morris JS, Lippman SM, Shureiqi I. PMID: 18198215.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    209. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. PMID: 18172274.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    210. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. PMID: 17975167.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    211. Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research. Cancer Res. 2007 Oct 01; 67(19):8989-93. Hoque A, Parnes HL, Stefanek ME, Heymach JV, Brown PH, Lippman SM. PMID: 17895292.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    212. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Sep 19; 99(18):1375-83. Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman SM, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA, Thompson IM. PMID: 17848673.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    213. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. J Clin Oncol. 2007 Jul 20; 25(21):3076-81. Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA. PMID: 17634486.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    214. The convergent development of molecular-targeted drugs for cancer treatment and prevention. Clin Cancer Res. 2007 Jul 15; 13(14):4035-41. Lippman SM, Heymach JV. PMID: 17634526.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    215. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Jul 04; 99(13):1025-35. Moinpour CM, Darke AK, Donaldson GW, Thompson IM, Langley C, Ankerst DP, Patrick DL, Ware JE, Ganz PA, Shumaker SA, Lippman SM, Coltman CA. PMID: 17596576.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    216. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. PMID: 17575242.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    217. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol. 2007 May 20; 25(15):1974-8. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. PMID: 17513803.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    218. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007 May 20; 25(15):2093-9. Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, Parker BJ, Bearden JD, Dakhil S, Gross HM, Lippman S, Albain KS. PMID: 17513815.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    219. Finasteride decreases the risk of prostatic intraepithelial neoplasia. J Urol. 2007 Jul; 178(1):107-9; discussion 110. Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman SM, Coltman CA. PMID: 17499284.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    220. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. J Urol. 2007 May; 177(5):1749-52. Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman SM, Coltman CA. PMID: 17437804.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    221. Molecular signatures of lung cancer--toward personalized therapy. N Engl J Med. 2007 Jan 04; 356(1):76-8. Herbst RS, Lippman SM. PMID: 17202459.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    222. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2007 Mar; 21(3):743-53. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, Lippman SM. PMID: 17167069.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    223. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need. Cancer Res. 2006 Dec 15; 66(24):11540-9. Herberman RB, Pearce HL, Lippman SM, Pyenson BS, Alberts DS. PMID: 17158189.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    224. The dilemma and promise of cancer chemoprevention. Nat Clin Pract Oncol. 2006 Oct; 3(10):523. Lippman SM. PMID: 17019426.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    225. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1977-83. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR. PMID: 17035408.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    226. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst. 2006 Aug 16; 98(16):1128-33. Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA. PMID: 16912265.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    227. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1479-84. Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman SM, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED. PMID: 16896036.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    228. The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1485-9. Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. PMID: 16896037.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    229. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA. Cancer Res. 2006 Jul 15; 66(14):7111-8. Liang ZD, Lippman SM, Wu TT, Lotan R, Xu XC. PMID: 16849557.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    230. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205. Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, Clayman GL, Weber RS, Lippman SM, Goldberg LH, Wei Q. PMID: 16841033.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    231. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK, AACR Task Force on Cancer Prevention . PMID: 16778094.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    232. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Jun 21; 295(23):2727-41. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, National Surgical Adjuvant Breast and Bowel Project (NSABP) . PMID: 16754727.
      View in: PubMed   Mentions: 428     Fields:    Translation:Humans
    233. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006 Jun 20; 24(18):2948-57. American Society of Clinical Oncology , Ganz PA, Kwan L, Somerfield MR, Alberts D, Garber JE, Offit K, Lippman SM. PMID: 16702579.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    234. Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res. 2006 May 15; 12(10):3109-14. Lippman SM, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R. PMID: 16707609.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    235. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman SM, Wu X. PMID: 16638786.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    236. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006 Apr 05; 98(7):441-50. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. PMID: 16595780.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    237. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. PMID: 16609032.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    238. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res. 2006 Mar 15; 66(6):2893-903. Lippman SM, Lee JJ. PMID: 16540634.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    239. Identification and characterization of the human retinoid X receptor alpha gene promoter. Gene. 2006 May 10; 372:118-27. Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman SM, Clifford JL. PMID: 16517099.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    240. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. PMID: 16368944.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    241. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11486-92. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM. PMID: 16357157.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    242. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene. 2005 Dec 15; 24(56):8268-76. Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu XC. PMID: 16170369.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    243. Statins and cancer prevention. Nat Rev Cancer. 2005 Dec; 5(12):930-42. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. PMID: 16341084.
      View in: PubMed   Mentions: 277     Fields:    Translation:HumansAnimals
    244. RARbeta1': primed to fight retinoid resistance in lung carcinogenesis. J Natl Cancer Inst. 2005 Nov 16; 97(22):1632-3. Sabichi AL, Xu X, Lippman SM. PMID: 16288110.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    245. Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol. 2005 Nov 10; 23(32):8161-4. Thompson IM, Tangen CM, Klein EA, Lippman SM. PMID: 16278467.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    246. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. . 2005 Nov; 4(11):1740-6. Hsi LC, Xi X, Wu Y, Lippman SM. PMID: 16275995.
      View in: PubMed   Mentions:
    247. Cigarettes: a smoking gun in cancer chemoprevention. J Natl Cancer Inst. 2005 Sep 21; 97(18):1319-21. Mayne ST, Lippman SM. PMID: 16174848.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    248. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res. 2005 Sep 15; 65(18):8442-7. Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman SM, Feinmark SJ, Oehlen B, Weinstein IB. PMID: 16166323.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    249. Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited. J Clin Oncol. 2005 Oct 20; 23(30):7460-6. Klein EA, Tangen CM, Goodman PJ, Lippman SM, Thompson IM. PMID: 16157937.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    250. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. PMID: 16148695.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    251. Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways. Clin Cancer Res. 2005 Sep 01; 11(17):6097-9. Lippman SM, Gibson N, Subbaramaiah K, Dannenberg AJ. PMID: 16144906.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    252. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005 Jul 15; 65(14):6189-98. Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG. PMID: 16024620.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    253. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. PMID: 16030104.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    254. Advances in the biology of lung cancer chemoprevention. J Clin Oncol. 2005 May 10; 23(14):3186-97. Hirsch FR, Lippman SM. PMID: 15886305.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    255. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005 May 01; 23(13):2900-2. Ewer MS, Lippman SM. PMID: 15860848.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    256. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):826-9. Xu XC, Lee JJ, Wu TT, Hoque A, Ajani JA, Lippman SM. PMID: 15824151.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    257. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005 Aug; 26(8):1368-73. Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. PMID: 15802297.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    258. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol. 2005 Mar 20; 23(9):1911-20. Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman SM. PMID: 15774783.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    259. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia. 2005 Mar; 7(3):280-93. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman SM, Menter DG. PMID: 15799828.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    260. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005 Feb 01; 23(4):759-65. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. PMID: 15681519.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    261. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis. 2005 Apr; 26(4):785-91. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. PMID: 15661803.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    262. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005 Jan 19; 97(2):94-102. Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA. PMID: 15657339.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    263. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005 Jan 10; 23(2):346-56. Lippman SM, Sudbø J, Hong WK. PMID: 15637397.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    264. Cancer prevention: strong science and real medicine. J Clin Oncol. 2005 Jan 10; 23(2):249-53. Lippman SM, Levin B. PMID: 15637388.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    265. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005 Jan 10; 23(2):254-66. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. PMID: 15637389.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    266. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005; 2(5):436-42. Cook ED, Moody-Thomas S, Anderson KB, Campbell R, Hamilton SJ, Harrington JM, Lippman SM, Minasian LM, Paskett ED, Craine S, Arnold KB, Probstfield JL. PMID: 16315648.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    267. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res. 2004 Dec 01; 64(23):8778-81. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. PMID: 15574791.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    268. Can selenium prevent colorectal cancer? A signpost from epidemiology. J Natl Cancer Inst. 2004 Nov 17; 96(22):1645-7. Duffield-Lillico AJ, Shureiqi I, Lippman SM. PMID: 15547171.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    269. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1704-9. Sabichi AL, Subbarayan V, Llansa N, Lippman SM, Menter DG. PMID: 15533896.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    270. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1710-6. Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman SM, Menter DG. PMID: 15533897.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    271. The convergence of cancer prevention and therapy in early-phase clinical drug development. Cancer Cell. 2004 Oct; 6(4):321-6. Abbruzzese JL, Lippman SM. PMID: 15488755.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    272. Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 01; 22(19):3848-51. Lippman SM, Levin B, Brenner DE, Gordon GB, Aldige CR, Kramer BS, Garber JE, Hawk E, Ganz PA, Somerfield MR, Writing Committee of the ASCO Cancer Prevention Committee . PMID: 15353541.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    273. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004 May 27; 350(22):2239-46. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA. PMID: 15163773.
      View in: PubMed   Mentions: 549     Fields:    Translation:HumansCTClinical Trials
    274. Science peels the onion of selenium effects on prostate carcinogenesis. J Natl Cancer Inst. 2004 May 05; 96(9):645-7. Taylor PR, Parnes HL, Lippman SM. PMID: 15126594.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    275. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 01; 350(14):1405-13. Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. PMID: 15070790.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    276. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):36-44. Sabichi AL, Lippman SM. PMID: 15179622.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    277. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Int J Oncol. 2004 Apr; 24(4):879-84. Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, Lippman SM, Sahin A. PMID: 15010825.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    278. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res. 2004 Mar 01; 10(5):1733-42. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R. PMID: 15014026.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    279. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73. Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF. PMID: 15014005.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    280. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004 Apr 30; 279(18):19191-200. Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman SM, Menter DG. PMID: 14985354.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    281. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol. 2003 Dec; 44(6):650-5. Thompson IM, Klein EA, Lippman SM, Coltman CA, Djavan B. PMID: 14644115.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    282. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1518-22. Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman SM. PMID: 14693746.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    283. Molecular based treatment of oral cancer. Oral Oncol. 2003 Dec; 39(8):749-58. Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. PMID: 13679198.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    284. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003 Nov 15; 98(10):2214-23. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, Kies MS, Glisson BS, Diaz EM, Clayman G, Morrison WH, Liu DD, Blumenschein G, Lippman SM, Schommer D, Gillenwater A, Goepfert H, Hong WK. PMID: 14601092.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    285. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol. 2003 Dec 15; 21(24):4546-52. Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman S, Recant W, El-Naggar AK, Stenson K, Lippman SM, Hong WK, Vokes EE. PMID: 14597742.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCellsCTClinical Trials
    286. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003 Oct; 76(4):1001-7; discussion 1007-8. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. PMID: 14529975.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    287. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study. Ann Surg Oncol. 2003 Oct; 10(8):870-5. Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman SM. PMID: 14527904.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    288. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5. Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. PMID: 12866024.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    289. Frontiers in cancer prevention research. Cancer Res. 2003 Sep 15; 63(18):5649-55. Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman SM. PMID: 14522879.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    290. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3660-6. Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC, Yu Y. PMID: 14506155.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    291. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9968-73. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM. PMID: 12909723.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    292. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem. 2003 Oct 17; 278(42):41338-46. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG. PMID: 12900420.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    293. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide. Clin Cancer Res. 2003 Jul; 9(7):2400-5. Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman SM. PMID: 12855611.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    294. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17; 349(3):215-24. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA. PMID: 12824459.
      View in: PubMed   Mentions: 631     Fields:    Translation:HumansCTClinical Trials
    295. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. . 2003 May; 2(5):453-9. Clifford JL, Yang X, Walch E, Wang M, Lippman SM. PMID: 12748307.
      View in: PubMed   Mentions:
    296. Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res. 2003 Apr 01; 63(7):1470-4. Liang Z, Lippman SM, Kawabe A, Shimada Y, Xu XC. PMID: 12670892.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    297. The selenium and vitamin E cancer prevention trial. World J Urol. 2003 May; 21(1):21-7. Klein EA, Lippman SM, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 12756490.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    298. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia. 2003 Mar-Apr; 5(2):121-7. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman SM. PMID: 12659684.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    299. SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol. 2003 Jan-Feb; 21(1):59-65. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C. PMID: 12684129.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    300. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 2003 Jan; 9(1):228-34. Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman SM, Kripke ML, Ananthaswamy HN. PMID: 12538474.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    301. COX-2 inhibitors and other NSAIDs in bladder and prostate cancer. Prog Exp Tumor Res. 2003; 37:163-78. Sabichi AL, Lippman SM. PMID: 12795054.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    302. Cancer prevention science and practice. Cancer Res. 2002 Sep 15; 62(18):5119-25. Lippman SM, Hong WK. PMID: 12234971.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    303. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res. 2002 Sep; 8(9):2835-42. Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman SM. PMID: 12231524.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    304. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30. Shin DM, Glisson BS, Khuri FR, Lippman SM, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK. PMID: 12124833.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    305. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002 Jul; 8(7):2067-72. Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman SM. PMID: 12114405.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    306. Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2002 Jun; 11(6):587-90. Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM. PMID: 12050101.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    307. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8. Wu X, Lippman SM, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR. PMID: 12019158.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    308. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res. 2002 Feb 15; 62(4):1178-83. Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, Lippman SM. PMID: 11861401.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    309. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002. Clin Cancer Res. 2002 Feb; 8(2):305-13. Lippman SM, Hong WK. PMID: 11839646.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    310. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 2002 Feb; 8(2):314-46. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman SM, Von Hoff DD. PMID: 11839647.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    311. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene. 2002 Jan 17; 21(3):411-8. Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R, Xu XC. PMID: 11821953.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    312. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002 Jan 15; 20(2):364-70. Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM. PMID: 11786562.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    Scott's Networks
    Concepts (992)
    Derived automatically from this person's publications.
    _
    Co-Authors (95)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _